Inventor · disambiguated record
Matthew Halpert
Also filed as: HALPERT MATTHEW · HALPERT MATTHEW M
0 granted patents·11 pending applications·0 citations·filing 2016–2023
Top patents by PatentIndex Score
11 records- 0167US2022213440A1Dendritic cell immunotherapyBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 0255US2025186486A1Potentiation of durable antitumor immunity by multifactorial immune modulationBAYLOR COLLEGE MEDICINE·Filed 2023·Application pending·0 cites
- 0353US2018127717A1Dendritic cell immunotherapyBAYLOR COLLEGE MEDICINE·Filed 2016·Application pending·0 cites
- 0448US2022387493A1Method for producing cytotoxic effector memory t-cells for car t-cell treatment of cancerBAYLOR COLLEGE MEDICINE·Filed 2020·Application pending·0 cites
- 0534US2018117084A1Methods for enhancing an immune response with a ctla-4 antagonistBAYLOR COLLEGE MEDICINE·Filed 2016·Application pending·0 cites
- 0633US2024335401A1Substituted phenethylamine for treating inflammation and psychological disordersSYNAPTIVE THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 0733US2023131989A1Cannabinoid compositions and methods of using for the treatment of non-eosinophilic inflammation and inflammatory disordersMEDTERRA PHARMA LLC·Filed 2022·Application pending·0 cites
- 0833US2024366638A1Psilocybin analogs for treating psychological disordersSYNAPTIVE THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 0933US2023067205A1Cannabinoid compositions and methods of using for the treatment of non-eosinophilic inflammation and inflammatory disordersMEDTERRA PHARMA LLC·Filed 2022·Application pending·0 cites
- 1031US2022387352A1Cannabinoid compositions and methods of using for the treatment of non-eosinophilic inflammation and inflammatory disordersMEDTERRA PHARMA LLC·Filed 2022·Application pending·0 cites
- 1129US2022031616A1Aerosolized CBD Liposomes for the treatment of Asthma and other pulmonary inflammatory disordersHALPERT MATTHEW·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew Halpert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →